Post-Market Clinical Follow-up Study of A-SPINE's Products

Sponsor
A-Spine Asia Co., Ltd. (Industry)
Overall Status
Recruiting
CT.gov ID
NCT04848376
Collaborator
(none)
200
1
36
5.6

Study Details

Study Description

Brief Summary

This is a post-market clinical follow-up study that use questionnaires such as Visual Analog Scale (VAS), the Neck Disability Index (NDI), or the Oswestry Disability Index (ODI) to compare the clinical improvement effects before and after surgery.

Condition or Disease Intervention/Treatment Phase
  • Device: (1) SmartLoc (2) SmartLoc Evo (3) Winloc(4) Vigor PEEK Cervical Disc Spacer (5) Combo C (6) Polymer Lumbar Disc Spacer (7) X'Plo (8) Rainboo (9) Combo L

Detailed Description

The purpose of study is to confirm the safety and and performance of the A-SPINE's products for using 2 years. This post-market clinical follow-up study use questionnaires such as Visual Analog Scale (VAS), the Neck Disability Index (NDI), or the Oswestry Disability Index (ODI) to evaluate the clinical improvement effects. Subjects will be evaluated at pre-operation, 6 months, 12 months, and 2 years post treatment. Finally, analyze the clinical outcome, fusion rate, and adverse events.

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Post-Market Clinical Follow-up Study of A-SPINE's Products
Actual Study Start Date :
Sep 9, 2019
Anticipated Primary Completion Date :
Sep 8, 2022
Anticipated Study Completion Date :
Sep 8, 2022

Arms and Interventions

Arm Intervention/Treatment
Spine surgery

Use these system: (1) SmartLoc (2) SmartLoc Evo(3) Winloc (4) Vigor PEEK Cervical Disc Spacer (5) Combo C (6) Polymer Lumbar Disc Spacer (7) X'Plo (8) Rainboo (9) Combo L

Device: (1) SmartLoc (2) SmartLoc Evo (3) Winloc(4) Vigor PEEK Cervical Disc Spacer (5) Combo C (6) Polymer Lumbar Disc Spacer (7) X'Plo (8) Rainboo (9) Combo L
As long as there are patients using the above device, conduct questionnaire interview.

Outcome Measures

Primary Outcome Measures

  1. Visual Analogue Scale- Change from baseline at 2 year [Change from baseline at 2 year]

    Visual Analogue Scale is a patient-reported outcome measure. The scale ranges from 0 to 10. A score of 0 represents no pain, while a score of 10 represents extreme pain. Compare baseline and postoperative improvement VAS scores.

Secondary Outcome Measures

  1. Neck Disability Index [Baseline, 6 months, 12 months, 24 months]

    The NDI is a questionnaire that is commonly used in clinical trials to measure the self-reported functional status of patients with neck pain.The ten questions are measured on a 6-point scale from 0 (no disability) to 5 (full disability). Compare baseline and postoperative improvement NDI scores.

  2. Oswestry Disability Index [Baseline, 6 months,12 months, 24 months]

    The ODI is a questionnaire that is commonly used in clinical trials to measure the self-reported functional status of patients with neck pain.The ten questions are measured on a 6-point scale from 0 (no disability) to 5 (full disability). Compare baseline and postoperative improvement ODI scores.

  3. Number of Device-related Adverse Events [Baseline, 6 months,12 months, 24 months]

    Adverse events associated with the device will be assessed at each follow-up visit and the number of cases at the 2-year follow-up will be counted.

  4. Fusion Rate [Baseline, 6 months,12 months, 24 months]

    Use X-ray or CT to detect the spine fusion.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Subject is above 20 years of age;

  • Subject is indicated for A-SPINE Spinal Fixation System;

  • Subject is willing and able to provide informed consent to participate in the study;

  • Subject is willing and able to understand the purpose of the study, his/her role, and is available to return to the clinic/hospital for all required follow-up visits.

Exclusion Criteria:
  • Subjects will be excluded if, in the opinion of the Investigator, the subject does not qualify based on approved labeling requirements or Subject Inclusion Criteria.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Taichung Tzu Chi Hospital Taichung Taiwan 427213

Sponsors and Collaborators

  • A-Spine Asia Co., Ltd.

Investigators

  • Principal Investigator: Bryan Huang, MD, Taichung Tzu Chi Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
A-Spine Asia Co., Ltd.
ClinicalTrials.gov Identifier:
NCT04848376
Other Study ID Numbers:
  • REC108-16
First Posted:
Apr 19, 2021
Last Update Posted:
Apr 19, 2021
Last Verified:
Apr 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 19, 2021